Analysts think ANRO stock price could increase by 117%
Jan 27, 2025, 12:25 PM
-37.45%
What does ANRO do
Alto Neuroscience, a clinical-stage biopharmaceutical company based in Los Altos, California, focuses on developing psychiatric drugs using its Precision Psychiatry Platform. The company has five clinical-stage assets targeting depression and schizophrenia, with an IPO on February 2, 2024.
7 analysts think ANRO stock price will increase by 117.02%. The current median analyst target is $10.20 compared to a current stock price of $4.70. The lowest analysts target is $4.04 and the highest analyst target is $18.90.
📡️ Health Care
Price Target
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.